Qingcui Song
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Qingcui Song has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Xiaoxia Zhu
Department of Radiation Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
3 shared publications Min Li
Department of Precision Biomedical Key Laboratory, Liaocheng People’s Hospital, Liaocheng, Shandong, China
2 shared publicationsXinyu Zhang
School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, China
2 shared publicationsYuan Chen
School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, China
2 shared publications- Baozhong Wang
Department of Oncology, Liaocheng People's Hospital, Affiliated to Shandong University and Clinical School of Shandong First Medical University, Liaocheng, 252000, PR China
1 shared publication Bo Fu
Department of Precision Biomedical Key Laboratory, Liaocheng People's Hospital, China; Shandong Provincial Key Medical and Health Laboratory of Precision Medicine for Aging Intervention and Active Health, Liaocheng, China
1 shared publication
Latest Publications
- Open Access
- 30 July 2025
- Published by Frontiers Media SA in Oncology Reviews
- Vol. 19, 1637372
METTL1 in human cancers: recognition of their functions, mechanisms and therapeutic value
Methyltransferase-like 1 (METTL1) is a methyltransferase that modulates the RNA methylation process and has been increasingly investigated in cancer research over the past decade. The review aims to summarize the diverse roles of METTL1 in various cancers, focusing on the mechanisms underlying tumorigenesis, progression, and metastasis. Furthermore, the therapeutic value and targeting strategies for METTL1 are also discussed to provide the foundation for further development of METTL1-targeted therapies. The article integrates recent research findings to highlight significant discoveries regarding METTL1, emphasizing its potential as a therapeutic target in cancer treatment.
- 30 July 2025
- Published by Frontiers Media SA in Oncology Reviews
- Vol. 19, 1637372
Open AccessMETTL1 in human cancers: recognition of their functions, mechanisms and therapeutic value
Methyltransferase-like 1 (METTL1) is a methyltransferase that modulates the RNA methylation process and has been increasingly investigated in cancer research over the past decade. The review aims to summarize the diverse roles of METTL1 in various cancers, focusing on the mechanisms underlying tumorigenesis, progression, and metastasis. Furthermore, the therapeutic value and targeting strategies for METTL1 are also discussed to provide the foundation for further development of METTL1-targeted therapies. The article integrates recent research findings to highlight significant discoveries regarding METTL1, emphasizing its potential as a therapeutic target in cancer treatment.
- 23 June 2025
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1871 (7) , 167961
METTL1-mediated m7G modification of NEK1 mRNA promotes the proliferation of oral squamous cell carcinoma
- 23 June 2025
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1871 (7) , 167961
METTL1-mediated m7G modification of NEK1 mRNA promotes the proliferation of oral squamous cell carcinoma
- 26 September 2019
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 64 (11) , 3355-3356
Glypican-1 as a Therapy Target in Esophageal Squamous Cell Carcinoma
- 26 September 2019
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 64 (11) , 3355-3356
Glypican-1 as a Therapy Target in Esophageal Squamous Cell Carcinoma
- 1 September 2019
- Published by Elsevier in Experimental Cell Research
- Vol. 382 (1) , 111450
MTA1 promotes the invasion and migration of oral squamous carcinoma by inducing epithelial–mesenchymal transition via the hedgehog signaling pathway
- 1 September 2019
- Published by Elsevier in Experimental Cell Research
- Vol. 382 (1) , 111450
MTA1 promotes the invasion and migration of oral squamous carcinoma by inducing epithelial–mesenchymal transition via the hedgehog signaling pathway
- Open Access
- 14 August 2013
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 32 (1) , 54
MTA1 promotes nasopharyngeal carcinoma growth in vitro and in vivo
Background: The prognostic value of metastasis-associated gene 1 (MTA1) in nasopharyngeal carcinoma (NPC) has been suggested. However, there is still no direct evidence that MTA1 promotes NPC growth in vivo. In this study, we aimed to investigate the function of MTA1 in the regulation of NPC cell proliferation and tumorigenesisin vitroandin vivo.Methods: Stable MTA1 knockdown or overexpression NPC cell lines were employed. The effects of MTA1 depletion or overexpression on cell proliferation, colony formation, cell cycle progression were examined by MTT, colony formation and flow cytometry assay. The effects of MTA1 depletion on tumor growth in vivo were examined in mouse xenograft model.Results: MTA1knockdown or overexpression drastically changed the proliferation, colony formation and cell cycle of NPC cellsin vitro. MTA1depletion significantly suppressed NPC tumorigenesisin vivo.Conclusion: MTA1 promotes NPC cell proliferation via enhancing G1 to S phase transition, leading to increased tumor growth. Targeting MTA1 is a promising approach to reduce tumor burden of NPC.
- 14 August 2013
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 32 (1) , 54
Open AccessMTA1 promotes nasopharyngeal carcinoma growth in vitro and in vivo
Background: The prognostic value of metastasis-associated gene 1 (MTA1) in nasopharyngeal carcinoma (NPC) has been suggested. However, there is still no direct evidence that MTA1 promotes NPC growth in vivo. In this study, we aimed to investigate the function of MTA1 in the regulation of NPC cell proliferation and tumorigenesisin vitroandin vivo.Methods: Stable MTA1 knockdown or overexpression NPC cell lines were employed. The effects of MTA1 depletion or overexpression on cell proliferation, colony formation, cell cycle progression were examined by MTT, colony formation and flow cytometry assay. The effects of MTA1 depletion on tumor growth in vivo were examined in mouse xenograft model.Results: MTA1knockdown or overexpression drastically changed the proliferation, colony formation and cell cycle of NPC cellsin vitro. MTA1depletion significantly suppressed NPC tumorigenesisin vivo.Conclusion: MTA1 promotes NPC cell proliferation via enhancing G1 to S phase transition, leading to increased tumor growth. Targeting MTA1 is a promising approach to reduce tumor burden of NPC.
- Open Access
- 20 April 2012
- Published by Spandidos Publications in Oncology Reports
- Vol. 28 (1) , 218-224
MTA1 gene silencing inhibits invasion and alters the microRNA expression profile of human lung cancer cells
Metastasis-associated gene 1 (MTA1) is involved in the carcinogenesis and metastasis of many human carcinomas. However, its exact role in non-small cell lung cancer (NSCLC) is still unclear. Using immunohistochemistry analysis, we recently identified MTA1 to be associated with the progression of NSCLC. Here, we carried out further analysis on the effect of MTA1 knockdown in an NSCLC cell line on cell functions and the global microRNA (miRNA) expression profile. We succeeded in establishing the MTA1 knockdown NSCLC cell line using RNA interference (RNAi), and found that the silencing of MTA1 resulted in the effective inhibition of the invasive ability of NSCLC cells, but not of the cell growth in vitro. We performed an miRNA microarray analysis and demonstrated for the first time that MTA1 knockdown significantly changed the expression of some miRNAs in NSCLC cells. Among them, some have a well-characterized association with cancer progression, e.g. miR-125b, miR-210, miR-103, miR-194 and miR-500. In summary, it is evident from our results that MTA1 functions in regulating the invasive phenotype of lung cancer cells and this regulation may be through altered miRNA expression. The interaction between MTA1 and the miRNAs which contributes to lung cancer is worthy of further investigation.
- 20 April 2012
- Published by Spandidos Publications in Oncology Reports
- Vol. 28 (1) , 218-224
Open AccessMTA1 gene silencing inhibits invasion and alters the microRNA expression profile of human lung cancer cells
Metastasis-associated gene 1 (MTA1) is involved in the carcinogenesis and metastasis of many human carcinomas. However, its exact role in non-small cell lung cancer (NSCLC) is still unclear. Using immunohistochemistry analysis, we recently identified MTA1 to be associated with the progression of NSCLC. Here, we carried out further analysis on the effect of MTA1 knockdown in an NSCLC cell line on cell functions and the global microRNA (miRNA) expression profile. We succeeded in establishing the MTA1 knockdown NSCLC cell line using RNA interference (RNAi), and found that the silencing of MTA1 resulted in the effective inhibition of the invasive ability of NSCLC cells, but not of the cell growth in vitro. We performed an miRNA microarray analysis and demonstrated for the first time that MTA1 knockdown significantly changed the expression of some miRNAs in NSCLC cells. Among them, some have a well-characterized association with cancer progression, e.g. miR-125b, miR-210, miR-103, miR-194 and miR-500. In summary, it is evident from our results that MTA1 functions in regulating the invasive phenotype of lung cancer cells and this regulation may be through altered miRNA expression. The interaction between MTA1 and the miRNAs which contributes to lung cancer is worthy of further investigation.